708 Stroke Prevention by Non-vitamin K Oral Anticoagulant (NOAC) Agents in the Absence of Atrial Fibrillation: Meta-analysis of Randomized Controlled Trials

Vitamin K ◽

Stroke Prevention ◽

Oral Anticoagulant ◽

Meta Analysis ◽

Controlled Trials ◽

Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies

Frontiers in Aging Neuroscience ◽

10.3389/fnagi.2018.00258 ◽

2018 ◽

Vol 10 ◽

Cited By ~ 12

Author(s):

Chi Zhang ◽

Zhi-Chun Gu ◽

Long Shen ◽

Mang-Mang Pan ◽

Yi-Dan Yan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cognitive Impairment ◽

Vitamin K ◽

Real World ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

GW29-e0301 Left atrial appendage closure versus warfarin for stroke prevention in patients with atrial fibrillation: A meta-analysis of randomized controlled trials

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2018.08.664 ◽

2018 ◽

Vol 72 (16) ◽

pp. C143

Author(s):

Jianbing Zhu ◽

Zeqi Zheng

Keyword(s):

Atrial Fibrillation ◽

Stroke Prevention ◽

Left Atrial ◽

Left Atrial Appendage ◽

Meta Analysis ◽

Atrial Appendage ◽

Controlled Trials ◽

Left Atrial Appendage Closure ◽

Risk of clinically relevant bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/s0167-5273(13)70556-4 ◽

2013 ◽

Vol 164 (2) ◽

pp. S12

Author(s):

J.S.W. Kwong ◽

Y.Y. Lam ◽

B.P. Yan ◽

C.M. Yu

Keyword(s):

Atrial Fibrillation ◽

Stroke Prevention ◽

Meta Analysis ◽

Oral Anticoagulants ◽

New Oral Anticoagulants ◽

Controlled Trials ◽

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2017.05.015 ◽

2017 ◽

Vol 116 (8) ◽

pp. 591-598 ◽

Cited By ~ 4

Author(s):

Kang-Ling Wang ◽

Chun-Chih Chiu ◽

Doreen Su-Yin Tan ◽

Chun-Yi Lin ◽

En-Yu Lai ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Randomized Controlled ◽

Asian Patients

Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.05.059 ◽

2016 ◽

Vol 218 ◽

pp. 235-239 ◽

Cited By ~ 2

Author(s):

Jalaj Garg ◽

Rahul Chaudhary ◽

Parasuram Krishnamoorthy ◽

Chandrasekar Palaniswamy ◽

Neeraj Shah ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Factor Xa ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Phase Ii And Iii

NOVEL ORAL ANTICOAGULANTS AND CONCOMITANT ANTIPLATELET THERAPY FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)60416-2 ◽

2014 ◽

Vol 63 (12) ◽

pp. A416

Author(s):

Shashi Kumar ◽

Stephan B. Danik ◽

Robert K. Altman ◽

Conor D. Barrett ◽

Gary S. Roubin ◽

...

Keyword(s):

Atrial Fibrillation ◽

Antiplatelet Therapy ◽

Stroke Prevention ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Novel Oral Anticoagulants ◽

Controlled Trials ◽

SAFETY AND EFFICACY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)31020-9 ◽

2018 ◽

Vol 71 (11) ◽

pp. A479

Author(s):

Nelson Telles Garcia ◽

Khagendra Dahal ◽

Nachiket Apte ◽

Pratap Reddy ◽

Paari Dominic

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Atrial Fibrillation Ablation ◽

Controlled Trials ◽

Safety And Efficacy ◽

Risk of Intracranial Hemorrhage Caused by Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation (from a Network Meta-Analysis of Randomized Controlled Trials)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.09.011 ◽

2021 ◽

Author(s):

Meina Lv ◽

Tingting Wu ◽

Shaojun Jiang ◽

Wenjun Chen ◽

Jinhua Zhang

Keyword(s):

Atrial Fibrillation ◽

Intracranial Hemorrhage ◽

Stroke Prevention ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Controlled Trials ◽

LEFT ATRIAL APPENDAGE OCCLUSION FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2015.07.458 ◽

2015 ◽

Vol 31 (10) ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

H. Hanif ◽

E. Belley-Cote ◽

B. Neupane ◽

R. Whitlock

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Stroke Prevention ◽

Left Atrial ◽

Left Atrial Appendage ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Left Atrial Appendage Occlusion

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials

European Heart Journal ◽

10.1093/eurheartj/ehy802 ◽

2018 ◽

Vol 40 (19) ◽

pp. 1492-1500 ◽

Cited By ~ 14

Author(s):

Kang-Ling Wang ◽

Renato D Lopes ◽

Manesh R Patel ◽

Harry R Büller ◽

Doreen Su-Yin Tan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Efficacy And Safety ◽

Reduced Dose ◽